These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9228993)

  • 21. [Ibopamine--clinical results].
    Kleber FX
    Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
    Marchionni N; Conti A; De Alfieri W; Di Bari M; Ferrucci L; Lombardi A; Moschi G; Vannucci A
    J Clin Pharmacol; 1986 Jan; 26(1):74-7. PubMed ID: 3512618
    [No Abstract]   [Full Text] [Related]  

  • 23. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for mortality in users of ibopamine.
    Feenstra J; in't Veld BA; van der Linden PD; Grobbee DE; Stricker BH
    Br J Clin Pharmacol; 1998 Jul; 46(1):71-7. PubMed ID: 9690952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of ibopamine in cardiac insufficiency in auricular fibrillation. Presentation of a case].
    Barriales V; Martínez Trabanco I; Richard JM; Cortina A
    Rev Clin Esp; 1989 Mar; 184(5):265. PubMed ID: 2772298
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug of the month. Ibopamine (Scandine, Idopamil)].
    Scheen AJ
    Rev Med Liege; 1994 Jun; 49(6):365-6. PubMed ID: 8047755
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

  • 29. Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):897-902. PubMed ID: 2487550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibopamine in the treatment of heart failure.
    Man in't Veld AJ
    Am J Med; 1991 May; 90(5B):50S-54S. PubMed ID: 1675552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
    Cadel A; Brusoni B; Pirelli P; Osculati G; Rovati A; Fanciulli R; Carati L; Valagussa F
    Arzneimittelforschung; 1986 Feb; 36(2A):376-9. PubMed ID: 3707653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibopamine--how should it be used?
    Bussmann WD; Wienhöfer K; Frik R
    Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ibopamine, a dopamine congener, on arrhythmias in heart failure.
    Storstein L
    Cardiology; 1990; 77 Suppl 5():30-5. PubMed ID: 1980632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
    Kleber FX; Thyroff-Friesinger U
    Z Kardiol; 1991; 80 Suppl 8():113. PubMed ID: 1796629
    [No Abstract]   [Full Text] [Related]  

  • 37. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
    Holubarsch C; Just H
    Cardiology; 1990; 77 Suppl 5():1-8. PubMed ID: 2279251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of ibopamine in patients with chronic heart failure.
    Metra M; Dei Cas L
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I22-31. PubMed ID: 7743695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.